ad image

Galapagos

1 / 1
Gilead Sciences
Clinical Trials

Gilead and Galapagos Announce Efficacy and Safety Results of Filgotinib Through 52 Weeks in FINCH 1 and FINCH 3 Studies in Rheumatoid Arthritis

Gilead Sciences

PR-M10-19-NI-017Oct 11, 2019
Gilead Sciences
Collaboration

Gilead and Galapagos Enter Into Transformative Research and Development Collaboration

Gilead Sciences

PR-M07-19-NI-046Jul 18, 2019
1 / 1